Ticker | Status | Jurisdiction | Filing Date | CP Start | CP End | CP Loss | Deadline |
---|
Ticker | Case Name | Status | CP Start | CP End | Deadline | Settlement Amt |
---|
Ticker | Name | Date | Analyst Firm | Up/Down | Target ($) | Rating Change | Rating Current |
---|
Medical Marijuana, Inc. (OTC:MJNA) has announced its financial results for the year ending December 31, 2021, and provided an overview of recent operational highlights.
“2021 was a pivotal year for Medical Marijuana, Inc – a year focused on our mission to establish new markets internationally and to bring access to safe and effective cannabis-based products to millions worldwide,” Blake Schroeder, the company’s CEO, said. “I’m proud of the progress we made in achieving that mission. Medical Marijuana, Inc. is leading the way in becoming the first global cannabis company. We will continue to utilize our first mover advantage in these markets while optimizing and growing our existing operations.”
Medical Marijuana’s shares traded 7.4074% higher at $0.0261 per share at the time of writing.
Photo: Courtesy of Chris Briggs on Unsplash
Posted In: MJNA